Please wait while we open this resource.
K
Clinical reviews
SODIUM POLYSTYRENE IS UNSAFE AND SHOULD NOT BE PRESCRIBED FOR THE TREATMENT OF HYPERKALEMIA: PRIMUM NON NOCERE!
Université de Lorraine, Centre d’Investigations Cliniques- Plurithématique, CHRU Nancy; Princess Grace Hospital, Monaco; University of Michigan School of Medicine
PDF20239 pages706 KB
The article critically evaluates the use of 'old generation' potassium binders, specifically sodium polystyrene sulfonate (SPS), in managing hyperkalemia. It emphasizes the absence of randomized data supporting their chronic use and outlines the associated risks, including fluid overload and unpredictable potassium lowering. The authors advocate for newer potassium binders, such as patiromer and sodium zirconium cyclosilicate, which have shown better safety profiles and tolerability, enabling improved management of hyperkalemia in patients with chronic kidney disease.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CARDIOVASCULAR COMPLICATIONS IN CHRONIC KIDNEY DISEASE: A REVIEW FROM THE EUROPEAN RENAL AND CARDIOVASCULAR MEDICINE WORKING GROUP OF THE EUROPEAN RENAL ASSOCIATION
Same clinical topic · Nephrology
THE ASSOCIATION BETWEEN DUAL RAAS INHIBITION AND RISK OF ACUTE KIDNEY INJURY AND HYPERKALEMIA IN PATIENTS WITH DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Same clinical topic · Nephrology
OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology
OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology
ACUTE GLOMERULONEPHRITIS
Same clinical topic · Nephrology
DISEASE MODIFICATION IN LUPUS NEPHRITIS: TOWARDS A PATHOPHYSIOLOGY-BASED TREATMENT PARADIGM
Same clinical topic · Nephrology
Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes
Same clinical topic · Nephrology
CURRENT UNDERSTANDING OF SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS IN CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Same clinical topic · Nephrology
A COMPREHENSIVE REVIEW OF ACUTE CARDIO-RENAL SYNDROME: NEED FOR NOVEL BIOMARKERS
Same clinical topic · Nephrology